Literature DB >> 25908727

Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia.

Mary McGrae McDermott1.   

Abstract

Lower extremity peripheral artery disease (PAD) is frequently underdiagnosed, in part because of the wide variety of leg symptoms manifested by patients with PAD and in part because of the high prevalence of asymptomatic PAD. In primary care medical practices, 30% to 60% of patients with PAD report no exertional leg symptoms and ≈45% to 50% report exertional leg symptoms that are not consistent with classic intermittent claudication. The prevalence and extent of functional impairment and functional decline in PAD may also be underappreciated. Functional impairment and functional decline are common in PAD, even among those who are asymptomatic. Lower extremity ischemia is also associated with pathophysiologic changes in calf skeletal muscle, including smaller calf muscle area, increased calf muscle fat content, impaired leg strength, and impaired metabolic function. People with severe PAD have poorer peroneal nerve conduction velocity compared with people with mild PAD or no PAD. The degree of ischemia-related pathophysiologic changes in lower extremity muscles and peripheral nerves of people with PAD are associated with the degree of functional impairment. New interventions are needed to improve functional performance and prevent mobility loss in the large number of patients with PAD, including in those who are asymptomatic or who have exertional leg symptoms other than claudication.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  intermittent claudication; peripheral arterial disease

Mesh:

Year:  2015        PMID: 25908727      PMCID: PMC4410164          DOI: 10.1161/CIRCRESAHA.114.303517

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  73 in total

1.  Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning: the women's health and aging study.

Authors:  M M McDermott; L Fried; E Simonsick; S Ling; J M Guralnik
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

Review 2.  The ankle-brachial index for peripheral artery disease screening and cardiovascular disease prediction among asymptomatic adults: a systematic evidence review for the U.S. Preventive Services Task Force.

Authors:  Jennifer S Lin; Carin M Olson; Eric S Johnson; Evelyn P Whitlock
Journal:  Ann Intern Med       Date:  2013-09-03       Impact factor: 25.391

3.  Six-minute walk is a better outcome measure than treadmill walking tests in therapeutic trials of patients with peripheral artery disease.

Authors:  Mary M McDermott; Jack M Guralnik; Michael H Criqui; Kiang Liu; Melina R Kibbe; Luigi Ferrucci
Journal:  Circulation       Date:  2014-07-01       Impact factor: 29.690

Review 4.  Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; David Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Graham Nichol; Nina P Paynter; Pamela J Schreiner; Paul D Sorlie; Joel Stein; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-01-01       Impact factor: 29.690

Review 5.  The treadmill is a better functional test than the 6-minute walk test in therapeutic trials of patients with peripheral artery disease.

Authors:  William R Hiatt; R Kevin Rogers; Eric P Brass
Journal:  Circulation       Date:  2014-07-01       Impact factor: 29.690

6.  Phosphorus 31 nuclear magnetic resonance spectroscopy suggests a mitochondrial defect in claudicating skeletal muscle.

Authors:  I I Pipinos; A D Shepard; P V Anagnostopoulos; A Katsamouris; M D Boska
Journal:  J Vasc Surg       Date:  2000-05       Impact factor: 4.268

7.  Correlation of patient-reported symptom outcomes and treadmill test outcomes after treatment for aortoiliac claudication.

Authors:  Timothy P Murphy; Matthew R Reynolds; David J Cohen; Judith G Regensteiner; Joseph M Massaro; Donald E Cutlip; Emile R Mohler; Joselyn Cerezo; Niki C Oldenburg; Claudia C Thum; Suzanne Goldberg; Alan T Hirsch
Journal:  J Vasc Interv Radiol       Date:  2013-07-29       Impact factor: 3.464

8.  Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial.

Authors:  Mary M McDermott; Kiang Liu; Jack M Guralnik; Michael H Criqui; Bonnie Spring; Lu Tian; Kathryn Domanchuk; Luigi Ferrucci; Donald Lloyd-Jones; Melina Kibbe; Huimin Tao; Lihui Zhao; Yihua Liao; W Jack Rejeski
Journal:  JAMA       Date:  2013-07-03       Impact factor: 56.272

Review 9.  Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis.

Authors:  F Gerald R Fowkes; Diana Rudan; Igor Rudan; Victor Aboyans; Julie O Denenberg; Mary M McDermott; Paul E Norman; Uchechukwe K A Sampson; Linda J Williams; George A Mensah; Michael H Criqui
Journal:  Lancet       Date:  2013-08-01       Impact factor: 79.321

10.  Oxidative damage and myofiber degeneration in the gastrocnemius of patients with peripheral arterial disease.

Authors:  Dustin J Weiss; George P Casale; Panagiotis Koutakis; Aikaterini A Nella; Stanley A Swanson; Zhen Zhu; Dimitrios Miserlis; Jason M Johanning; Iraklis I Pipinos
Journal:  J Transl Med       Date:  2013-09-25       Impact factor: 5.531

View more
  57 in total

1.  Peripheral artery disease, calf skeletal muscle mitochondrial DNA copy number, and functional performance.

Authors:  Mary M McDermott; Charlotte A Peterson; Robert Sufit; Luigi Ferrucci; Jack M Guralnik; Melina R Kibbe; Tamar S Polonsky; Lu Tian; Michael H Criqui; Lihui Zhao; James H Stein; Lingyu Li; Christiaan Leeuwenburgh
Journal:  Vasc Med       Date:  2018-05-08       Impact factor: 3.239

2.  A compendium on peripheral arterial disease.

Authors:  John P Cooke; Zhen Chen
Journal:  Circ Res       Date:  2015-04-24       Impact factor: 17.367

3.  Platelet-Derived MRP-14 Induces Monocyte Activation in Patients With Symptomatic Peripheral Artery Disease.

Authors:  Rebecca Dann; Tarik Hadi; Emilie Montenont; Ludovic Boytard; Dornaszadat Alebrahim; Jordyn Feinstein; Nicole Allen; Russell Simon; Krista Barone; Kunihiro Uryu; Yu Guo; Caron Rockman; Bhama Ramkhelawon; Jeffrey S Berger
Journal:  J Am Coll Cardiol       Date:  2018-01-02       Impact factor: 24.094

Review 4.  Clinical Assessment of Peripheral Arterial Disease in the Office: What Do the Guidelines Say?

Authors:  Srini Tummala; Derek Scherbel
Journal:  Semin Intervent Radiol       Date:  2019-02-05       Impact factor: 1.513

5.  Body-weight goals, trends, and weight-loss techniques among patients with peripheral arterial disease.

Authors:  O Addison; R Yang; M C Serra
Journal:  Nutr Health       Date:  2018-12-23

Review 6.  Disruption of mitochondrial quality control in peripheral artery disease: New therapeutic opportunities.

Authors:  Cintia B Ueta; Katia S Gomes; Márcio A Ribeiro; Daria Mochly-Rosen; Julio C B Ferreira
Journal:  Pharmacol Res       Date:  2016-11-19       Impact factor: 7.658

7.  Exercise Rehabilitation for Peripheral Artery Disease: A REVIEW.

Authors:  Mary M McDermott
Journal:  J Cardiopulm Rehabil Prev       Date:  2018-03       Impact factor: 2.081

Review 8.  HIV and Cardiovascular Disease: Update on Clinical Events, Special Populations, and Novel Biomarkers.

Authors:  Kaku So-Armah; Matthew S Freiberg
Journal:  Curr HIV/AIDS Rep       Date:  2018-06       Impact factor: 5.071

Review 9.  Time and the Metrics of Aging.

Authors:  Luigi Ferrucci; Morgan E Levine; Pei-Lun Kuo; Eleanor M Simonsick
Journal:  Circ Res       Date:  2018-09-14       Impact factor: 17.367

Review 10.  Cell therapy for peripheral artery disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Curr Opin Pharmacol       Date:  2018-02-13       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.